chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: red patch on her arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red patch on her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red patch on her arm). At the time of the report, ERYTHEMA (red patch on her arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Pain, Vomiting
Clinical narrative: Terrible body aches; Difficulty breathing; Headaches; Vomiting; A spontaneous report  was received from a consumer, concerning a 70-year-old female patient who received Moderna (mRNA-1273) and experienced terrible body aches, headaches, vomiting and a lot of difficulty breathing.   The patient's medical history included asthma, high blood pressure and diabetes. Concomitant medication included unspecified asthma, high blood pressure and diabetes medication.   On 18-Feb-2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection.  On 18-Feb-2021, within 24 hours after vaccination in evening, the patient experienced terrible body aches, headaches, vomiting and a lot of difficulty breathing. The patient was treated with tylenol.  Action taken with the mRNA-1273 was considered as unknown.  The outcome of the events terrible body aches, headaches, vomiting and a lot of difficulty breathing were considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: fever; headache; fatigue; swelling; Hardness; Injection site soreness; A Spontaneous  report was received from a consumer concerning a Female patient,  who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Pyrexia, Headache, Fatigue, Injection site swelling, Injection site induration and injection site pain. The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination   On 11 Feb  2021 , prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown)  via unknown route and unknown location for prophylaxis of COVID-19 infection .   On unknown date Patient developed Pyrexia, Headache, Fatigue, Injection site swelling, Injection site induration and injection site pain.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome for the event Pyrexia, Headache, Fatigue, Injection site swelling, Injection site induration and injection site pain was reported as unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; headache; fatigue; swelling; Hardness; Injection site soreness; A Spontaneous  report was received from a consumer concerning a Female patient,  who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Pyrexia, Headache, Fatigue, Injection site swelling, Injection site induration and injection site pain. The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination   On 11 Feb  2021 , prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown)  via unknown route and unknown location for prophylaxis of COVID-19 infection .   On unknown date Patient developed Pyrexia, Headache, Fatigue, Injection site swelling, Injection site induration and injection site pain.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome for the event Pyrexia, Headache, Fatigue, Injection site swelling, Injection site induration and injection site pain was reported as unknown.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: diagnosis with COVID 19, COVID positive after taking the 1st shot; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosis with COVID 19, COVID positive after taking the 1st shot) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced COVID-19 (diagnosis with COVID 19, COVID positive after taking the 1st shot). At the time of the report, COVID-19 (diagnosis with COVID 19, COVID positive after taking the 1st shot) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, SARS-CoV-2 test: (Positive) Positive-detected.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications. No treatment reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: Date of SARS-CoV2 testing was provided.; Sender's Comments: Based on mechanism of action of mRNA 1273 and etiology of event Covid 19, event is unlikely related to the vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: small red area and it has increased to 6 inches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (small red area and it has increased to 6 inches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (small red area and it has increased to 6 inches). At the time of the report, VACCINATION SITE ERYTHEMA (small red area and it has increased to 6 inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.        No relevant concomitant medications were reported.  Treatment for the events included hot, ice and antihistamine.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: still has redness in the right arm he was vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (still has redness in the right arm he was vaccinated) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (still has redness in the right arm he was vaccinated). At the time of the report, VACCINATION SITE ERYTHEMA (still has redness in the right arm he was vaccinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were provided  No treatment was reported   Reporter did not allow further contact
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: feeling foggy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling foggy) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feeling foggy). At the time of the report, FEELING ABNORMAL (feeling foggy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were provided by reporter  Treatment details were not provided.   Reporter did not allow further contact
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site haemorrhage, Vaccination site discharge, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (sore arm in injection site), injection site hemorrhage (bleeding from injection site) and vaccination site discharge (thinks vaccine leaked out with blood) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 013L20A) for COVID-19 immunization. No medical history reported. On Jan 20, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 19, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; unspecified dose. On Jan 20, 2021, patient experienced vaccination site pain (sore arm in injection site). On Feb 19, 2021, patient experienced injection site hemorrhage (bleeding from injection site) and vaccination site discharge (thinks vaccine leaked out with blood). On Jan 23, 2021, vaccination site pain (sore arm in injection site) outcome: unknown. On Feb 19, 2021, injection site hemorrhage (bleeding from injection site) and vaccination site discharge (thinks vaccine leaked out with blood) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular and mRNA-1273 (Moderna COVID-19 vaccine), unknown route: unknown. Concomitant medications not reported. The patient's treatment unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Itching; Redness; Rash on left arm/also on back just about the waist/bumps; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), ERYTHEMA (Redness) and RASH (Rash on left arm/also on back just about the waist/bumps) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 13-Feb-2021, the patient experienced PRURITUS (Itching), ERYTHEMA (Redness) and RASH (Rash on left arm/also on back just about the waist/bumps). At the time of the report, PRURITUS (Itching) had resolved, ERYTHEMA (Redness) was resolving and RASH (Rash on left arm/also on back just about the waist/bumps) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant product use was not provided by the reporter  No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Gout, Pain in extremity
Clinical narrative: Diagnosed with gout; having pain in right leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (having pain in right leg) and GOUT (Diagnosed with gout) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     Concurrent medical conditions included Gout (The patient was diagnosed with gout.).    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (having pain in right leg). On an unknown date, the patient experienced GOUT (Diagnosed with gout). At the time of the report, PAIN IN EXTREMITY (having pain in right leg) and GOUT (Diagnosed with gout) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications was provided. No treatment information was provided.   Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site rash, Type IV hypersensitivity reaction, Urticaria
Clinical narrative: delayed injection site reactions; red welts on arm; injection site itch; injection site rash; injection site sore; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (delayed injection site reactions), URTICARIA (red welts on arm), INJECTION SITE PRURITUS (injection site itch), INJECTION SITE RASH (injection site rash) and INJECTION SITE PAIN (injection site sore) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H20) for COVID-19 vaccination.     The patient's past medical history included No adverse event (NO historical condition not reported.).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced URTICARIA (red welts on arm), INJECTION SITE PRURITUS (injection site itch), INJECTION SITE RASH (injection site rash) and INJECTION SITE PAIN (injection site sore). On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (delayed injection site reactions). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (delayed injection site reactions), URTICARIA (red welts on arm), INJECTION SITE PRURITUS (injection site itch), INJECTION SITE RASH (injection site rash) and INJECTION SITE PAIN (injection site sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Feb-2021: No specific follow-up information recorded.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Tongue discomfort
Clinical narrative: burning sensation on tongue; fever; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISCOMFORT (burning sensation on tongue) and PYREXIA (fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for an unknown indication.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced TONGUE DISCOMFORT (burning sensation on tongue) and PYREXIA (fever). At the time of the report, TONGUE DISCOMFORT (burning sensation on tongue) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever 101 F°), chills and myalgia in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included diabetes. On Jan 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; unspecified dose. On an unknown date, patient experienced pyrexia  (fever 101 F°), chills and myalgia. At the time of the report, pyrexia (fever 101 F°): resolving; and chills and myalgia outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications or treatment information provided. This case linked to MOD-2021-018128 (patient link).
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rhinorrhoea, Vomiting
Clinical narrative: runny nose; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), NAUSEA (nausea) and VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (No reported medical history.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced RHINORRHOEA (runny nose), NAUSEA (nausea) and VOMITING (vomiting). At the time of the report, RHINORRHOEA (runny nose), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Incorrect dose administered, Vaccination site pain
Clinical narrative: dry mouth; inappropriate dose; arm extremely sore; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), INCORRECT DOSE ADMINISTERED (inappropriate dose) and VACCINATION SITE PAIN (arm extremely sore) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history).   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On an unknown date, the patient experienced DRY MOUTH (dry mouth), INCORRECT DOSE ADMINISTERED (inappropriate dose) and VACCINATION SITE PAIN (arm extremely sore). At the time of the report, DRY MOUTH (dry mouth), INCORRECT DOSE ADMINISTERED (inappropriate dose) and VACCINATION SITE PAIN (arm extremely sore) outcome was unknown.             Treatment details not provided.  No relevant concomitant medications were reported.      This case was linked to MOD-2021-018719 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Urticaria, Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: all over her abdomen, she was covered in hives, about size of quarter, bumpy, red and itchy; lips became swollen; Injection site became hard; Injection site grew in size to about 3x4 inches; Injection site became red; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (all over her abdomen, she was covered in hives, about size of quarter, bumpy, red and itchy), LIP SWELLING (lips became swollen), VACCINATION SITE INDURATION (Injection site became hard), VACCINATION SITE SWELLING (Injection site grew in size to about 3x4 inches) and VACCINATION SITE ERYTHEMA (Injection site became red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy, Blood pressure high and High cholesterol. Concomitant products included SPIRONOLACTONE, METOPROLOL and METFORMIN for an unknown indication.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced URTICARIA (all over her abdomen, she was covered in hives, about size of quarter, bumpy, red and itchy), LIP SWELLING (lips became swollen), VACCINATION SITE INDURATION (Injection site became hard), VACCINATION SITE SWELLING (Injection site grew in size to about 3x4 inches) and VACCINATION SITE ERYTHEMA (Injection site became red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (all over her abdomen, she was covered in hives, about size of quarter, bumpy, red and itchy), LIP SWELLING (lips became swollen), VACCINATION SITE INDURATION (Injection site became hard), VACCINATION SITE SWELLING (Injection site grew in size to about 3x4 inches) and VACCINATION SITE ERYTHEMA (Injection site became red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site). On 16-Jan-2021, VACCINATION SITE RASH (Rash at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Started itching around the site; Has turned red; Swollen around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Started itching around the site), VACCINATION SITE ERYTHEMA (Has turned red) and VACCINATION SITE SWELLING (Swollen around the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Sensitive skin. Concomitant products included LOSARTAN, METOPROLOL and HYDROCHLOROTHIAZIDE for Hypertension.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Started itching around the site), VACCINATION SITE ERYTHEMA (Has turned red) and VACCINATION SITE SWELLING (Swollen around the injection site). The patient was treated with BACITRACIN ZINC, POLYMYXIN B SULFATE (AQUAPHOR ANTIBIOTIC) for Itchy, at an unspecified dose and frequency. On 20-Feb-2021, VACCINATION SITE SWELLING (Swollen around the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Started itching around the site) outcome was unknown and VACCINATION SITE ERYTHEMA (Has turned red) was resolving. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow-up received as Telephone contact report , contains non-significant information. On 27-Apr-2021: Follow-up contains, Non-significant information.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance
Clinical narrative: walking problems; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (walking problems) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (walking problems). At the time of the report, GAIT DISTURBANCE (walking problems) outcome was unknown.            No concomitant medications were reported. No treatment related information has been reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: Patient's Gender related information has been received.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling of body temperature change, Pain in extremity, Pyrexia
Clinical narrative: Arm is still massively sore; Hot and cold; Fever; Chills/wakes up about 0100 or 0200 with chills; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is still massively sore), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), PYREXIA (Fever), CHILLS (Chills/wakes up about 0100 or 0200 with chills) and FATIGUE (Very tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Arm is still massively sore), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), PYREXIA (Fever), CHILLS (Chills/wakes up about 0100 or 0200 with chills) and FATIGUE (Very tired). At the time of the report, PAIN IN EXTREMITY (Arm is still massively sore), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), PYREXIA (Fever), CHILLS (Chills/wakes up about 0100 or 0200 with chills) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drug were reported. The pharmacist asked the patient to take Tylenol as treatment. Patient was sipping water all day.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Stomach cramp; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramp) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramp). On 13-Jan-2021, ABDOMINAL PAIN UPPER (Stomach cramp) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Tachycardia
Clinical narrative: Fast heart beat; Sore arm; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Fast heart beat), PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever) and NAUSEA (Nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included Heart disorder (heart condition).    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced TACHYCARDIA (Fast heart beat), PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever) and NAUSEA (Nausea). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Fast heart beat), PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Body temperature, Epistaxis, Gingival bleeding, Pain
Clinical narrative: Tinnitus; A little bit of blood when he blew his nose; Bleeding gums; Shakes; Aches; Fever (99.7 degrees Fahrenheit); loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever (99.7 degrees Fahrenheit)), PAIN (Aches), EPISTAXIS (A little bit of blood when he blew his nose), GINGIVAL BLEEDING (Bleeding gums) and TREMOR (Shakes) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Factor V Leiden carrier (Discovered with Pulmonary Embolism) on 15-Apr-2021, Penicillin allergy, Thrombophlebitis on 13-Jun-2012, Osteoarthritis knee on 10-Jul-2017, Posterior vitreous detachment on 27-Nov-2018 and Tinnitus (Worsened on or about April 29 2021) since 15-Apr-2006. Concomitant products included RIVAROXABAN (XARELTO) from 01-Aug-2019 to an unknown date for Factor V Leiden mutation, COLECALCIFEROL (D3 50) from 01-Jan-2021 to an unknown date and MULTIVITAMINS [VITAMINS NOS] from 01-May-2002 to an unknown date for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PYREXIA (Fever (99.7 degrees Fahrenheit)), PAIN (Aches) and TREMOR (Shakes). In February 2021, the patient experienced ANOSMIA (loss of smell). On 18-Feb-2021, the patient experienced EPISTAXIS (A little bit of blood when he blew his nose) and GINGIVAL BLEEDING (Bleeding gums). On 29-Apr-2021, the patient experienced TINNITUS (Tinnitus). On 16-Feb-2021, PYREXIA (Fever (99.7 degrees Fahrenheit)), PAIN (Aches) and TREMOR (Shakes) had resolved. On 18-Feb-2021, EPISTAXIS (A little bit of blood when he blew his nose) and GINGIVAL BLEEDING (Bleeding gums) had resolved. At the time of the report, TINNITUS (Tinnitus) and ANOSMIA (loss of smell) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, SARS-CoV-2 test: positive (Positive) positive. On 15-Feb-2021, Body temperature: 37.6 (High) (99.7 degrees Fahrenheit).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received and contains updated concomitant medications RIVAROXABAN 10 mg daily for Factor V Leiden, added events- Tinnitus, Anosmia, updated outcome for events - Epistaxis, Gingival bleeding as recovered. On 31-Jul-2021: Follow up received and  contains no new information . On 02-Aug-2021: Follow up received and contain Lab results updated.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Tinnitus, Tremor
Clinical narrative: Tinnitus; A little bit of blood when he blew his nose; Bleeding gums; Shakes; Aches; Fever (99.7 degrees Fahrenheit); loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever (99.7 degrees Fahrenheit)), PAIN (Aches), EPISTAXIS (A little bit of blood when he blew his nose), GINGIVAL BLEEDING (Bleeding gums) and TREMOR (Shakes) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Factor V Leiden carrier (Discovered with Pulmonary Embolism) on 15-Apr-2021, Penicillin allergy, Thrombophlebitis on 13-Jun-2012, Osteoarthritis knee on 10-Jul-2017, Posterior vitreous detachment on 27-Nov-2018 and Tinnitus (Worsened on or about April 29 2021) since 15-Apr-2006. Concomitant products included RIVAROXABAN (XARELTO) from 01-Aug-2019 to an unknown date for Factor V Leiden mutation, COLECALCIFEROL (D3 50) from 01-Jan-2021 to an unknown date and MULTIVITAMINS [VITAMINS NOS] from 01-May-2002 to an unknown date for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PYREXIA (Fever (99.7 degrees Fahrenheit)), PAIN (Aches) and TREMOR (Shakes). In February 2021, the patient experienced ANOSMIA (loss of smell). On 18-Feb-2021, the patient experienced EPISTAXIS (A little bit of blood when he blew his nose) and GINGIVAL BLEEDING (Bleeding gums). On 29-Apr-2021, the patient experienced TINNITUS (Tinnitus). On 16-Feb-2021, PYREXIA (Fever (99.7 degrees Fahrenheit)), PAIN (Aches) and TREMOR (Shakes) had resolved. On 18-Feb-2021, EPISTAXIS (A little bit of blood when he blew his nose) and GINGIVAL BLEEDING (Bleeding gums) had resolved. At the time of the report, TINNITUS (Tinnitus) and ANOSMIA (loss of smell) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, SARS-CoV-2 test: positive (Positive) positive. On 15-Feb-2021, Body temperature: 37.6 (High) (99.7 degrees Fahrenheit).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received and contains updated concomitant medications RIVAROXABAN 10 mg daily for Factor V Leiden, added events- Tinnitus, Anosmia, updated outcome for events - Epistaxis, Gingival bleeding as recovered. On 31-Jul-2021: Follow up received and  contains no new information . On 02-Aug-2021: Follow up received and contain Lab results updated.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypokinesia, Muscular weakness, Pyrexia
Clinical narrative: Fever; Very Weak legs; she could not move around and slept on the floor, normally moves around with one crotch but last night she could not; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Very Weak legs), HYPOKINESIA (she could not move around and slept on the floor, normally moves around with one crotch but last night she could not), CHILLS (Chills) and PYREXIA (Fever) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced MUSCULAR WEAKNESS (Very Weak legs), HYPOKINESIA (she could not move around and slept on the floor, normally moves around with one crotch but last night she could not) and CHILLS (Chills). On 20-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, MUSCULAR WEAKNESS (Very Weak legs), HYPOKINESIA (she could not move around and slept on the floor, normally moves around with one crotch but last night she could not), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: tongue and lips felt funny; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tongue and lips felt funny) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 immunisation.     No medical history was provided by the reporter.  Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]), BUSPIRONE, METOPROLOL, LOSARTAN, ROSUVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PARAESTHESIA ORAL (tongue and lips felt funny). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at an unspecified dose and frequency. On 25-Jan-2021, PARAESTHESIA ORAL (tongue and lips felt funny) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site arm  (left arm) was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site arm  (left arm) was sore) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 immunisation.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site arm  (left arm) was sore). At the time of the report, VACCINATION SITE PAIN (injection site arm  (left arm) was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia
Clinical narrative: Chills; Shoulder pain; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), ARTHRALGIA (Shoulder pain) and MYALGIA (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021 at 8:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced CHILLS (Chills), ARTHRALGIA (Shoulder pain) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) on 25-Jan-2021 for Chills, Shoulder pain and Myalgia, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), ARTHRALGIA (Shoulder pain) and MYALGIA (Body aches) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications reported.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: dizziness; Nausea; headache; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (dizziness), NAUSEA (Nausea) and HEADACHE (headache) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure (Mentions high blood pressure) since an unknown date and Cholesterol since an unknown date.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced DIZZINESS (dizziness), NAUSEA (Nausea) and HEADACHE (headache). At the time of the report, DIZZINESS (dizziness), NAUSEA (Nausea) and HEADACHE (headache) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient takes regular medication for her high blood pressure and high cholesterol.  Treatment details: Advil (ibuprofen).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: hive on cheek; injection site warmth; injection site itchiness; 2.5 x 2.5 red area; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hive on cheek), VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE ERYTHEMA (2.5 x 2.5 red area) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20a) for COVID-19 immunisation.     Concomitant products included LEVOTHYROXINE and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE ERYTHEMA (2.5 x 2.5 red area). On an unknown date, the patient experienced URTICARIA (hive on cheek), VACCINATION SITE WARMTH (injection site warmth) and VACCINATION SITE PRURITUS (injection site itchiness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at an unspecified dose and frequency. At the time of the report, URTICARIA (hive on cheek), VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE ERYTHEMA (2.5 x 2.5 red area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Injection site pain, Myalgia, Pyrexia
Clinical narrative: Hard to walk; Injection site area is sore/pain at injection site; Feel achy muscles; Lil fever; very very tired; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hard to walk), INJECTION SITE PAIN (Injection site area is sore/pain at injection site), MYALGIA (Feel achy muscles), PYREXIA (Lil fever) and FATIGUE (very very tired) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 043L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced GAIT DISTURBANCE (Hard to walk), INJECTION SITE PAIN (Injection site area is sore/pain at injection site), MYALGIA (Feel achy muscles), PYREXIA (Lil fever) and FATIGUE (very very tired). At the time of the report, GAIT DISTURBANCE (Hard to walk), INJECTION SITE PAIN (Injection site area is sore/pain at injection site), MYALGIA (Feel achy muscles), PYREXIA (Lil fever) and FATIGUE (very very tired) outcome was unknown.      Concomitant product use was not provided by the reporter.  Treatment medication included paracetamol 650mg one dose on 18 Feb 2021 at noon time.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: The injection site is hot/warm; The injection site is swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (the injection site is hot/warm) and VACCINATION SITE SWELLING (the injection site is swollen) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (the injection site is hot/warm) and VACCINATION SITE SWELLING (the injection site is swollen). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (the injection site is hot/warm) and VACCINATION SITE SWELLING (the injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       2 weeks after receiving the vaccine, the patient's injection site was hot/warm and swollen. The patient has been putting ice pack on it. Then she contacted her doctor and who prescribed aspirin/Tylenol and told her to use the ice pack.  Concomitant medications were not reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Muscular weakness, Myalgia, Pain in extremity
Clinical narrative: Flu-like symptoms; Pain in arm; Arm felt weak/Not as strong as it used to be; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Pain in arm), MUSCULAR WEAKNESS (Arm felt weak/Not as strong as it used to be) and MYALGIA (Muscle aches) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included MELOXICAM (MOBIC), LORATADINE (CLARITINE), PANTOPRAZOLE and PARACETAMOL (TYLENOL) for an unknown indication.   On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Pain in arm), MUSCULAR WEAKNESS (Arm felt weak/Not as strong as it used to be) and MYALGIA (Muscle aches). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Pain in arm), MUSCULAR WEAKNESS (Arm felt weak/Not as strong as it used to be) and MYALGIA (Muscle aches) had not resolved.      No treatment was taken by the patient for the events.   This case was linked to MOD-2021-017196 (E2B Linked Report).; Sender's Comments:  MOD-2021-017196:Same patient: 1st dose case
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pain in extremity, Vaccination site warmth
Clinical narrative: Arm hurts a lot; Injection site is a little warm; Making her sweat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts a lot), VACCINATION SITE WARMTH (Injection site is a little warm) and HYPERHIDROSIS (Making her sweat) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts a lot), VACCINATION SITE WARMTH (Injection site is a little warm) and HYPERHIDROSIS (Making her sweat). At the time of the report, PAIN IN EXTREMITY (Arm hurts a lot), VACCINATION SITE WARMTH (Injection site is a little warm) and HYPERHIDROSIS (Making her sweat) had not resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Pharyngitis streptococcal
Clinical narrative: Strep throat; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGITIS STREPTOCOCCAL (Strep throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PHARYNGITIS STREPTOCOCCAL (Strep throat). The patient was treated with AMOXICILLIN for Pharyngitis streptococcal, at an unspecified dose and frequency. At the time of the report, PHARYNGITIS STREPTOCOCCAL (Strep throat) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications reported.